Active Not RecruitingNCT06442462

Study of SPG302 in Adults With Schizophrenia

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in Australia.

SchizophreniaOtherFrom 18 Years to 65 Years

In plain English

Key information made simple

This study exists to understand whether the medication SPG302 is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication SPG302 can give earlier or clearer feedback during care. For people living with Schizophrenia, being understood earlier and more clearly can shape the whole care journey. If the findings are useful, they could lead to earlier recognition and more informed decisions later on. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including CenExel CNS in Garden Grove, Box Hill Hospital - Eastern Health in Box Hill, and Multidisciplinary Alfred Psychiatry Research Centre (MAPrc) in Melbourne. Participation appears to involve a study treatment together with follow-up visits and routine safety or progress checks. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include other factors that could make participation unsuitable. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Interested?

Check my eligibility

Study reference: NCT06442462. Your email is the only field you need to provide here.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Australia.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com